Cargando…

Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes

INTRODUCTION: The diagnosis and assessment of neuropathy severity of diabetic sensorimotor polyneuropathy (DSPN) are mainly based on clinical neuropathy scores and electrophysiologic studies. This study aimed to determine whether quantitative thermal testing (QTT) can be used as a screening and foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yu-Chuan, Chuang, Yao-Chung, Chiu, Wen-Chan, Huang, Chih-Cheng, Cheng, Ben-Chung, Kuo, Chun-En Aurea, Lin, Ting-Yin, Chiang, Hui-Ching, Lai, Yun-Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083326/
https://www.ncbi.nlm.nih.gov/pubmed/37051142
http://dx.doi.org/10.3389/fnins.2023.1115242
_version_ 1785021484812468224
author Huang, Yu-Chuan
Chuang, Yao-Chung
Chiu, Wen-Chan
Huang, Chih-Cheng
Cheng, Ben-Chung
Kuo, Chun-En Aurea
Lin, Ting-Yin
Chiang, Hui-Ching
Lai, Yun-Ru
author_facet Huang, Yu-Chuan
Chuang, Yao-Chung
Chiu, Wen-Chan
Huang, Chih-Cheng
Cheng, Ben-Chung
Kuo, Chun-En Aurea
Lin, Ting-Yin
Chiang, Hui-Ching
Lai, Yun-Ru
author_sort Huang, Yu-Chuan
collection PubMed
description INTRODUCTION: The diagnosis and assessment of neuropathy severity of diabetic sensorimotor polyneuropathy (DSPN) are mainly based on clinical neuropathy scores and electrophysiologic studies. This study aimed to determine whether quantitative thermal testing (QTT) can be used as a screening and follow-up tool for DSPN of prediabetes and type 2 diabetes at baseline and at 1-year follow-up. METHODS: All patients were assessed using the Toronto Clinical Neuropathy Score (TCNS) and underwent electrophysiological testing, including a nerve conduction study (NCS) and QTT, at baseline and at a 1-year follow-up. The TCNS and the composite scores of nerve conduction were used to assess the severity of DSPN. The DSPN status at the 1-year follow-up was classified as remaining no DSPN, remaining DSPN, regression to no DSPN, or progression to DSPN. RESULTS: Diabetic sensorimotor polyneuropathy was initially diagnosed in 89 patients with prediabetes and type 2 diabetes (22%). The regressed to no DSPN in 29 patients and progressed to DSPN in 20 patients at the 1-year follow-up. TCNS was significantly correlated with composite scores of nerve conduction, hand cold detection threshold (CDT), hand warm detection threshold (WDT), foot CDT, and foot WDT. Stepwise logistic regression demonstrated that the foot CDT (p < 0.0001) was independently associated with the presence of DSPN. The TCNS, composite scores of the nerve conduction, hand WDT, hand CDT, foot WDT, and foot CDT were all statistically significant among the four different DSPN status groups at two different time periods (baseline and the 1-year follow-up). CONCLUSION: The foot CDT can be used as an initial screening tool for DSPN alternatively. The characteristics of nerve damage after 1 year of DSPN can be progressive or reversible, and the neurological functions of large and small fibers have a parallel trend, which can be objectively measured by NCS and QTT.
format Online
Article
Text
id pubmed-10083326
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100833262023-04-11 Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes Huang, Yu-Chuan Chuang, Yao-Chung Chiu, Wen-Chan Huang, Chih-Cheng Cheng, Ben-Chung Kuo, Chun-En Aurea Lin, Ting-Yin Chiang, Hui-Ching Lai, Yun-Ru Front Neurosci Neuroscience INTRODUCTION: The diagnosis and assessment of neuropathy severity of diabetic sensorimotor polyneuropathy (DSPN) are mainly based on clinical neuropathy scores and electrophysiologic studies. This study aimed to determine whether quantitative thermal testing (QTT) can be used as a screening and follow-up tool for DSPN of prediabetes and type 2 diabetes at baseline and at 1-year follow-up. METHODS: All patients were assessed using the Toronto Clinical Neuropathy Score (TCNS) and underwent electrophysiological testing, including a nerve conduction study (NCS) and QTT, at baseline and at a 1-year follow-up. The TCNS and the composite scores of nerve conduction were used to assess the severity of DSPN. The DSPN status at the 1-year follow-up was classified as remaining no DSPN, remaining DSPN, regression to no DSPN, or progression to DSPN. RESULTS: Diabetic sensorimotor polyneuropathy was initially diagnosed in 89 patients with prediabetes and type 2 diabetes (22%). The regressed to no DSPN in 29 patients and progressed to DSPN in 20 patients at the 1-year follow-up. TCNS was significantly correlated with composite scores of nerve conduction, hand cold detection threshold (CDT), hand warm detection threshold (WDT), foot CDT, and foot WDT. Stepwise logistic regression demonstrated that the foot CDT (p < 0.0001) was independently associated with the presence of DSPN. The TCNS, composite scores of the nerve conduction, hand WDT, hand CDT, foot WDT, and foot CDT were all statistically significant among the four different DSPN status groups at two different time periods (baseline and the 1-year follow-up). CONCLUSION: The foot CDT can be used as an initial screening tool for DSPN alternatively. The characteristics of nerve damage after 1 year of DSPN can be progressive or reversible, and the neurological functions of large and small fibers have a parallel trend, which can be objectively measured by NCS and QTT. Frontiers Media S.A. 2023-03-27 /pmc/articles/PMC10083326/ /pubmed/37051142 http://dx.doi.org/10.3389/fnins.2023.1115242 Text en Copyright © 2023 Huang, Chuang, Chiu, Huang, Cheng, Kuo, Lin, Chiang and Lai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Huang, Yu-Chuan
Chuang, Yao-Chung
Chiu, Wen-Chan
Huang, Chih-Cheng
Cheng, Ben-Chung
Kuo, Chun-En Aurea
Lin, Ting-Yin
Chiang, Hui-Ching
Lai, Yun-Ru
Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes
title Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes
title_full Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes
title_fullStr Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes
title_full_unstemmed Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes
title_short Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes
title_sort quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083326/
https://www.ncbi.nlm.nih.gov/pubmed/37051142
http://dx.doi.org/10.3389/fnins.2023.1115242
work_keys_str_mv AT huangyuchuan quantitativethermaltestingasascreeningandfollowuptoolfordiabeticsensorimotorpolyneuropathyinpatientswithtype2diabetesandprediabetes
AT chuangyaochung quantitativethermaltestingasascreeningandfollowuptoolfordiabeticsensorimotorpolyneuropathyinpatientswithtype2diabetesandprediabetes
AT chiuwenchan quantitativethermaltestingasascreeningandfollowuptoolfordiabeticsensorimotorpolyneuropathyinpatientswithtype2diabetesandprediabetes
AT huangchihcheng quantitativethermaltestingasascreeningandfollowuptoolfordiabeticsensorimotorpolyneuropathyinpatientswithtype2diabetesandprediabetes
AT chengbenchung quantitativethermaltestingasascreeningandfollowuptoolfordiabeticsensorimotorpolyneuropathyinpatientswithtype2diabetesandprediabetes
AT kuochunenaurea quantitativethermaltestingasascreeningandfollowuptoolfordiabeticsensorimotorpolyneuropathyinpatientswithtype2diabetesandprediabetes
AT lintingyin quantitativethermaltestingasascreeningandfollowuptoolfordiabeticsensorimotorpolyneuropathyinpatientswithtype2diabetesandprediabetes
AT chianghuiching quantitativethermaltestingasascreeningandfollowuptoolfordiabeticsensorimotorpolyneuropathyinpatientswithtype2diabetesandprediabetes
AT laiyunru quantitativethermaltestingasascreeningandfollowuptoolfordiabeticsensorimotorpolyneuropathyinpatientswithtype2diabetesandprediabetes